SI2513119T1 - 3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati - Google Patents

3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati

Info

Publication number: SI2513119T1
Authority: SI; Slovenia
Prior art keywords: cćisoquinoline; thiopyrano; tetrahydro; derivatives; cćisoquinoline derivatives
Prior art date: 2009-12-18

Application number

SI201030746T

Other languages

English (en)

Inventor

Dieter Flockerzi

Thomas Stengel

Alexander Mann

Harald Ohmer

Ulrich Kautz

Steffen Weinbrenner

Stefan Fischer

Christof Zitt

Armin Hatzelmann

Torsten Dunkern

Christian Hesslinger

Thomas Maier

Hermann Tenor

Clemens Braun

Raimund Kulzer

Degenhard Marx

Original Assignee

Takeda Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-12-18

Filing date

2010-12-15

Publication date

2014-10-30

2010-12-15 Application filed by Takeda Gmbh filed Critical Takeda Gmbh

2014-10-30 Publication of SI2513119T1 publication Critical patent/SI2513119T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Endocrinology (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Psychology (AREA)
Vascular Medicine (AREA)

SI201030746T 2009-12-18 2010-12-15 3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati SI2513119T1 (sl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP09179982		2009-12-18
US31555210P	2010-03-19	2010-03-19
EP10790569.7A EP2513119B1 (en)	2009-12-18	2010-12-15	3,4,4a,10b-tetrahydro-1h-thiopyrano-[4,3-c]isoquinoline derivatives
PCT/EP2010/069704 WO2011073231A1 (en)	2009-12-18	2010-12-15	3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4, 3-c] ISOQUINOLINE DERIVATIVES

Publications (1)

Publication Number	Publication Date
SI2513119T1 true SI2513119T1 (sl)	2014-10-30

Family

ID=41718903

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI201030746T SI2513119T1 (sl)	2009-12-18	2010-12-15	3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati

Country Status (29)

Country	Link
US (1)	US9018175B2 (sl)
EP (2)	EP2513119B1 (sl)
JP (1)	JP5645961B2 (sl)
KR (1)	KR20120123313A (sl)
CN (1)	CN102652136B (sl)
AR (1)	AR079451A1 (sl)
AU (1)	AU2010332955B8 (sl)
BR (1)	BR112012014058A8 (sl)
CA (1)	CA2784013A1 (sl)
CO (1)	CO6551705A2 (sl)
DK (1)	DK2513119T3 (sl)
EA (1)	EA023212B1 (sl)
ES (2)	ES2621291T3 (sl)
GE (1)	GEP20146105B (sl)
HR (1)	HRP20140893T1 (sl)
ME (1)	ME01914B (sl)
MX (1)	MX2012006696A (sl)
NZ (1)	NZ601115A (sl)
PH (1)	PH12012501125A1 (sl)
PL (1)	PL2513119T3 (sl)
PT (1)	PT2513119E (sl)
RS (1)	RS53544B1 (sl)
SG (2)	SG196785A1 (sl)
SI (1)	SI2513119T1 (sl)
SM (1)	SMT201400185B (sl)
TW (1)	TWI468411B (sl)
UA (1)	UA107689C2 (sl)
WO (1)	WO2011073231A1 (sl)
ZA (1)	ZA201204135B (sl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2013528912A (ja)	2010-06-07	2013-07-11	インフィニットパワーソリューションズ，インコーポレイテッド	再充電可能高密度電気化学素子
KR20140012989A (ko) *	2011-02-17	2014-02-04	시플라 리미티드	글리코피롤레이트 및 베타2-효능제의 조합
US20140113877A1 (en) *	2011-06-15	2014-04-24	Takeda Gmbh	Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c] isoquinoline compounds
WO2014016548A2 (en) *	2012-07-27	2014-01-30	Cipla Limited	Pharmaceutical composition
WO2014090990A1 (en) *	2012-12-13	2014-06-19	Ludwig Aigner	Leukotriene pathway antagonists for the treatment of dementia, cognitive deficits in parkinson's disease and/or learning and memory deficiencies in parkinson's disease
WO2014117947A1 (en)	2013-02-04	2014-08-07	Grünenthal GmbH	4-amino substituted condensed pyrimidine compounds as pde4 inhibitors
CN105121439A (zh)	2013-02-19	2015-12-02	辉瑞公司	作为pde4亚型抑制剂用于治疗cns和其他病症的氮杂苯并咪唑化合物
JP6713982B2 (ja)	2014-07-24	2020-06-24	ファイザー・インク	ピラゾロピリミジン化合物
KR102061952B1 (ko)	2014-08-06	2020-01-02	화이자 인코포레이티드	이미다조피리다진 화합물
WO2017089347A1 (en)	2015-11-25	2017-06-01	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
WO2022006470A1 (en)	2020-07-01	2022-01-06	Vanderbilt University	Methods of treatment for a kidney disease

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3899494A (en)	1970-05-13	1975-08-12	Sandoz Ltd	Substituted 6-phenyl benzo-naphthyridines
DE2047465A1 (de)	1970-09-26	1972-03-30	Farbwerke Hoechst AG, vorm Meister Lucius & Bruning, 6000 Frankfurt	Neue Oxdiazole und Verfahren zu lh rer Herstellung
CN1003445B (zh)	1984-10-03	1989-03-01	武田药品工业株式会社	噻唑烷二酮衍生物，其制备方法和用途
JPH01213284A (ja)	1988-02-22	1989-08-28	Sankyo Co Ltd	チエノピリミジン−２，４−ジオン誘導体
GB8828477D0 (en)	1988-12-06	1989-01-05	Riker Laboratories Inc	Medical aerosol formulations
ES2060040T5 (es)	1989-05-31	1999-09-16	Fisons Plc	Dispositivo y formulacion de inhalacion de medicamento.
GB8921222D0 (en)	1989-09-20	1989-11-08	Riker Laboratories Inc	Medicinal aerosol formulations
IE67185B1 (en)	1990-02-02	1996-03-06	Fisons Plc	Propellant compositions
DE4003272A1 (de)	1990-02-03	1991-08-08	Boehringer Ingelheim Kg	Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
EP0965335B1 (en)	1990-03-23	2003-09-17	Minnesota Mining And Manufacturing Company	Metered-dose aerosol formulations
CA2094266C (en)	1990-10-18	1999-06-01	Robert K. Schultz	Aerosol formulations of beclomethasone-17,21-dipropionate
AU650953B2 (en)	1991-03-21	1994-07-07	Novartis Ag	Inhaler
IL104068A (en)	1991-12-12	1998-10-30	Glaxo Group Ltd	Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
GB9213874D0 (en)	1992-06-30	1992-08-12	Fisons Plc	Process to novel medicament form
GB9306703D0 (en)	1993-03-31	1993-05-26	Fisons Plc	Inhalation device
IL111194A (en)	1993-10-08	1998-02-08	Fisons Plc	Process for the production of medicament formulations
SI0937074T1 (sl)	1996-11-11	2003-08-31	Altana Pharma Ag	Benzonaftiridini kot bronhialni terapevtiki
JP4672820B2 (ja)	1997-05-08	2011-04-20	メルクシャープエンドドームリミテッド	ＧＡＢＡα５リガンドとしての置換１，２，４−トリアゾロ［３，４−ａ］フタラジン誘導体
WO1998055481A1 (en)	1997-06-03	1998-12-10	Byk Gulden Lomberg Chemische Fabrik Gmbh	Benzonaphthyridine
EP1102579B1 (de)	1998-08-04	2003-03-19	Jago Research Ag	Medizinische aerosolformulierungen
US6397838B1 (en)	1998-12-23	2002-06-04	Battelle Pulmonary Therapeutics, Inc.	Pulmonary aerosol delivery device and method
EP1194244B1 (en)	1999-04-23	2005-12-21	Battelle Memorial Institute	Directionally controlled ehd aerosol sprayer
BR0009992A (pt)	1999-04-23	2002-01-08	Battelle Memorial Institute	Pulverizador de aerossol eletro-hidrodinâmico, aparelho e processo para administrar um aerossol e processo para produzir e administrar um aerossol
WO2001030757A1 (en)	1999-10-28	2001-05-03	Microcide Pharmaceuticals, Inc.	Drug discharge pump inhibitors
DE60105020T2 (de)	2000-06-07	2005-08-18	Almirall-Prodesfarma S.A.	6-phenylpyrrolopyrimidindion derivate
WO2002005616A1 (en)	2000-07-14	2002-01-24	Altana Pharma Ag	Novel 6-phenylphenanthridines
CA2425035A1 (en)	2000-10-09	2002-04-18	3M Innovative Properties Company	Medicinal aerosol formulations
JP2005504043A (ja)	2001-08-10	2005-02-10	パラチンテクノロジーズインク．	生物学的に活性な金属ペプチド類のペプチド模倣体類
GB0202254D0 (en)	2002-01-31	2002-03-20	Pfizer Ltd	Prevention of scarring
US20030216407A1 (en)	2002-01-31	2003-11-20	Pfizer Inc.	Use of PDE5 inhibitors in the treatment of scarring
AU2003253165A1 (en)	2002-08-13	2004-02-25	Warner-Lambert Company Llc	Pyrimidine fused bicyclic metalloproteinase inhibitors
CN1972684A (zh)	2004-04-23	2007-05-30	细胞基因公司	用于治疗和控制肺高血压的含有pde4调节剂的组合物以及其使用方法
US7589205B2 (en)	2004-09-08	2009-09-15	Nycomed Gmbh	3-thia-10-aza-phenanthrene derivatives
US7838521B2 (en)	2004-09-08	2010-11-23	Nycomed Gmbh	3-oxa-10-aza-phenanthrenes
JP4943858B2 (ja)	2004-11-17	2012-05-30	キッセイ薬品工業株式会社	芳香族アミド誘導体、それを含有する医薬組成物およびそれらの医薬用途
EP1858880A1 (en)	2005-03-09	2007-11-28	Nycomed GmbH	Amido-substituted 6-phenylphenanthridines
EP2148871A1 (en)	2007-04-23	2010-02-03	Sanofi-Aventis	Quinoline-carboxamide derivatives as p2y12 antagonists
US20140113877A1 (en) *	2011-06-15	2014-04-24	Takeda Gmbh	Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c] isoquinoline compounds

2010
- 2010-12-14 AR ARP100104617A patent/AR079451A1/es unknown
- 2010-12-15 UA UAA201208482A patent/UA107689C2/ru unknown
- 2010-12-15 AU AU2010332955A patent/AU2010332955B8/en not_active Ceased
- 2010-12-15 US US13/515,214 patent/US9018175B2/en not_active Expired - Fee Related
- 2010-12-15 SG SG2014000335A patent/SG196785A1/en unknown
- 2010-12-15 ES ES14164018.5T patent/ES2621291T3/es active Active
- 2010-12-15 ES ES10790569.7T patent/ES2505290T3/es active Active
- 2010-12-15 GE GEAP201012783A patent/GEP20146105B/en unknown
- 2010-12-15 PL PL10790569T patent/PL2513119T3/pl unknown
- 2010-12-15 EP EP10790569.7A patent/EP2513119B1/en active Active
- 2010-12-15 CN CN201080057293.7A patent/CN102652136B/zh not_active Expired - Fee Related
- 2010-12-15 RS RSP20140499 patent/RS53544B1/sr unknown
- 2010-12-15 DK DK10790569.7T patent/DK2513119T3/da active
- 2010-12-15 CA CA2784013A patent/CA2784013A1/en not_active Abandoned
- 2010-12-15 BR BR112012014058A patent/BR112012014058A8/pt not_active IP Right Cessation
- 2010-12-15 PH PH1/2012/501125A patent/PH12012501125A1/en unknown
- 2010-12-15 NZ NZ601115A patent/NZ601115A/en not_active IP Right Cessation
- 2010-12-15 KR KR1020127017957A patent/KR20120123313A/ko not_active Withdrawn
- 2010-12-15 EP EP14164018.5A patent/EP2813509B1/en active Active
- 2010-12-15 JP JP2012543701A patent/JP5645961B2/ja not_active Expired - Fee Related
- 2010-12-15 SG SG2012034732A patent/SG180824A1/en unknown
- 2010-12-15 SI SI201030746T patent/SI2513119T1/sl unknown
- 2010-12-15 PT PT107905697T patent/PT2513119E/pt unknown
- 2010-12-15 MX MX2012006696A patent/MX2012006696A/es active IP Right Grant
- 2010-12-15 HR HRP20140893AT patent/HRP20140893T1/hr unknown
- 2010-12-15 ME MEP-2014-114A patent/ME01914B/me unknown
- 2010-12-15 WO PCT/EP2010/069704 patent/WO2011073231A1/en not_active Ceased
- 2010-12-15 EA EA201200891A patent/EA023212B1/ru not_active IP Right Cessation
- 2010-12-17 TW TW99144591A patent/TWI468411B/zh not_active IP Right Cessation
2012
- 2012-05-24 CO CO12085785A patent/CO6551705A2/es active IP Right Grant
- 2012-06-06 ZA ZA2012/04135A patent/ZA201204135B/en unknown
2014
- 2014-12-11 SM SM201400185T patent/SMT201400185B/xx unknown

Also Published As

Publication number	Publication date
GEP20146105B (en)	2014-05-27
HRP20140893T1 (hr)	2014-11-07
MX2012006696A (es)	2012-07-17
AU2010332955B2 (en)	2015-01-22
ES2505290T3 (es)	2014-10-09
EP2513119A1 (en)	2012-10-24
SMT201400185B (it)	2015-01-15
EP2513119B1 (en)	2014-06-25
DK2513119T3 (da)	2014-10-06
TWI468411B (zh)	2015-01-11
CN102652136B (zh)	2014-11-26
AU2010332955A8 (en)	2015-05-28
EA201200891A1 (ru)	2013-01-30
HK1174326A1 (en)	2013-06-07
UA107689C2 (xx)	2015-02-10
ES2621291T3 (es)	2017-07-03
KR20120123313A (ko)	2012-11-08
NZ601115A (en)	2014-05-30
PT2513119E (pt)	2014-09-05
PH12012501125A1 (en)	2012-10-29
AR079451A1 (es)	2012-01-25
WO2011073231A1 (en)	2011-06-23
EA023212B1 (ru)	2016-05-31
US9018175B2 (en)	2015-04-28
US20120289474A1 (en)	2012-11-15
TW201130851A (en)	2011-09-16
AU2010332955A1 (en)	2012-08-02
ZA201204135B (en)	2013-03-27
BR112012014058A2 (pt)	2017-10-24
RS53544B1 (sr)	2015-02-27
CA2784013A1 (en)	2011-06-23
SG180824A1 (en)	2012-07-30
CO6551705A2 (es)	2012-10-31
BR112012014058A8 (pt)	2018-02-06
AU2010332955B8 (en)	2015-05-21
CN102652136A (zh)	2012-08-29
JP5645961B2 (ja)	2014-12-24
JP2013514308A (ja)	2013-04-25
SG196785A1 (en)	2014-02-13
ME01914B (me)	2015-05-20
PL2513119T3 (pl)	2014-11-28
EP2813509B1 (en)	2017-02-01
EP2813509A1 (en)	2014-12-17

Publication	Publication Date	Title
IL206765A0 (en)	2010-12-30	4,5-dihydro-oxazol-2-yl-amine derivatives
AP2012006216A0 (en)	2012-04-30	Benzimidazole-imidazole derivatives.
ZA201205788B (en)	2015-05-27	1,2,4-triazine-4-amine derivatives
IL241360A0 (en)	2015-11-30	Disubstituted 2-acetamido-5-aryl-4,2,1-triazole
IL210548A0 (en)	2011-03-31	Spiroaminodihydrothiazine derivatives
ZA201100799B (en)	2011-10-26	Imidazopyridin-2-one derivatives
SG10201506608RA (en)	2015-09-29	3-deazaneplanocin derivatives
IL210406A0 (en)	2011-03-31	Pyrrolopyridinylpyrimidin - 2 - ylamine derivatives
ZA201102449B (en)	2011-12-28	Morpholinopurine derivatives
ZA201102315B (en)	2012-06-27	7-piperidinoalkyl-3,4-dihyfroquinolone derivative
IL208336A0 (en)	2010-12-30	Pyrisazinone derivatives
IL210869A0 (en)	2011-04-28	Imidazothiadiazoles derivatives
SI2513119T1 (sl)	2014-10-30	3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati
IL211290A0 (en)	2011-04-28	New 2-amidothiadiazole derivatives
IL210613A0 (en)	2011-03-31	Novel acylaminobenzamide derivatives
ZA201005382B (en)	2011-10-26	Substituted heteroarylamide diazepinopyrimidone derivatives
IL210164A0 (en)	2011-03-31	Thiazolylpiperidine derivatives
IL207191A0 (en)	2010-12-30	Substituted heteroaylamide oxazepyrimidone derivatives
IL213424A0 (en)	2011-07-31	Quinazolinamide derivatives
EP2448934A4 (en)	2012-12-05	DERIVATIVES OF 2-CARBOXAMIDE-7-PIPERAZINYL-BENZOFURAN
ZA201008052B (en)	2012-04-25	2-phenyl-4-cyclopropyl-pyrimidine derivatives
MY165626A (en)	2018-04-18	1,2,4,-triazolone derivative
ZA201005346B (en)	2011-11-30	3,8-diaminotetrahydroquinoline derivative
GB2476643B (en)	2012-11-14	1,4-Dihydro-1,4-dioxonaphtalene derivatives as anticoagulants
IL213762A0 (en)	2011-07-31	1,1,1-trifluoro-2-hydroxypropyl compounds